{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T03:03:43Z","timestamp":1760151823786,"version":"build-2065373602"},"reference-count":22,"publisher":"American Academy of Insurance Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Insur Med"],"published-print":{"date-parts":[[2025]]},"abstract":"<jats:p>Leukemia is a broad term for a heterogenous group of hematologic malignancies that arise from the abnormal proliferation of leukocytes. It occurs most often in adults older than 55, but also is the most common cancer in children younger than 15, and accounts for more than 25% of cancer deaths in this age group. In this United States long term retrospective population-based analysis of 143,713 microscopically confirmed leukemia cases, mortality and survival study, 1975-2022, data is derived from the NCI Surveillance, Epidemiology and End-Results Programs, SEER*Stat software versions 8.4.5 and SEER*Stat 9.0.40.0, and, SEER Registry \u2013 Incidence - SEER Research Data, 8 Registries, Nov 2024 Sub (1975-2022). This comparative cohort entry time-period analysis is intended to provide age-adjusted epidemiologic, demographic, short and long-term survival and mortality data for convenient reference by all physicians, scientists, insurance underwriters, and others interested in cancer mortality follow-up.<\/jats:p>","DOI":"10.17849\/insm-52-3-1-32.1","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:54:31Z","timestamp":1760097271000},"page":"148-179","source":"Crossref","is-referenced-by-count":0,"title":["Leukemia \u2013 20-Year Comparative Survival and Mortality Analysis by Age, Sex, Race, Cohort Entry Time-Period, Disease Duration, Major Subtypes and Other Histologic Categories: A Systematic Review of 142,713 Cases for Diagnosis Years 1975-2022"],"prefix":"10.17849","volume":"52","author":[{"given":"Anthony F.","family":"Milano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7324","reference":[{"key":"i-52-3-148-ref01","article-title":"The History of Leukemia","author":"Ali","year":"2025","unstructured":"Ali Naheed, MD, PhD, ScD. The History of Leukemia. www.lll.org. Jan 15, 2025."},{"issue":"1","key":"i-52-3-148-ref02","series-title":"Leuk Res","first-page":"6","article-title":"The discovery and early understanding of leukemia","volume":"36","author":"Kampen","year":"2012","unstructured":"Kampen KR. The discovery and early understanding of leukemia. Leuk Res. 2012 Jan;36(1):6\u201313. doi: 10.1016\/j.leukres.2011.09.028. Epub 2011 Oct 26. PMID: 22033191."},{"issue":"4","key":"i-52-3-148-ref03","series-title":"Curr Oncol Rep","first-page":"472","article-title":"History of Leukemia, Revisited","volume":"27","author":"Ortiz-Hidalgo","year":"2025","unstructured":"Ortiz-Hidalgo C. History of Leukemia, Revisited. Curr Oncol Rep. 2025 Apr;27(4):472\u2013482. doi: 10.1007\/s11912-025-01658-2. Epub 2025 Mar 19. PMID: 40106215."},{"issue":"8","key":"i-52-3-148-ref04","series-title":"Journal of Cancer","first-page":"2326","article-title":"\u201cSecular trends in the incidence and survival of all leukemia types in the United States from 1975 to 2017.\u201d","volume":"12","author":"Yang,","year":"2021","unstructured":"Yang, Xiaorong,\nChen Hui,\nMan Jinyu,\nZhang Tongchao,\nYin Xiaolin,\nHe Qiufeng, and Lu Ming. 2021. \u201cSecular trends in the incidence and survival of all leukemia types in the United States from 1975 to 2017.\u201d Journal of Cancer 2021;12(8):2326\u201335."},{"article-title":"SEER*Explorer: An interactive website for SEER cancer statistics [Internet]","year":"2025","key":"i-52-3-148-ref05","unstructured":"SEER*Explorer: An interactive website for SEER cancer statistics [Internet]. Surveillance Research Program, National Cancer Institute; 2025 Apr 16. [cited 2025 Jun 25]. Available from: https:\/\/seer.cancer.gov\/statistics-network\/explorer\/. Data source(s): SEER Incidence Data, November 2024 Submission (1975-2022), SEER 21 registries."},{"article-title":"National Cancer Institute SEER*Stat software","author":"Surveillance Research Program","key":"i-52-3-148-ref06","unstructured":"Surveillance Research Program, National Cancer Institute SEER*Stat software (www.seer.cancer.gov\/seerstat) version 8.4.5 Surveillance, Epidemiology, and End Results."},{"article-title":"National Cancer Institute SEER*Stat software","author":"Surveillance Research Program","key":"i-52-3-148-ref07","unstructured":"Surveillance Research Program, National Cancer Institute SEER*Stat software (www.seer.cancer.gov\/seerstat) version 9.0.40.0."},{"key":"i-52-3-148-ref08","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER Research Data, 8 Registries, Nov 2024 Sub (1975-2022) - Linked To County Attributes - Time Dependent (1990-2023) Income\/Rurality, 1969-2023 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2025, based on the November 2024 submission."},{"key":"i-52-3-148-ref09","series-title":"Lancet","first-page":"1131","article-title":"Long-term survival of cancer patients achieved by the end of the 20th century: a period analysis","volume":"360","author":"Brenner","year":"2002","unstructured":"Brenner H. Long-term survival of cancer patients achieved by the end of the 20th century: a period analysis. Lancet 2002;360:1131\u201335."},{"key":"i-52-3-148-ref10","series-title":"JAMA","first-page":"2975","article-title":"Are Increasing 5-Year Survival Rates Evidence of Success Against Cancer","volume":"283","author":"Welch","year":"2000","unstructured":"Welch HG,\nSchwartz LM,\nWoloshin S. Are Increasing 5-Year Survival Rates Evidence of Success Against Cancer. JAMA 2000;283:2975\u20132978."},{"key":"i-52-3-148-ref11","series-title":"J Insur Med","first-page":"1","article-title":"Mortality Methodology and Analysis Seminar Text. Sponsored by the Association of Life Insurance Medical Directors of America","volume":"20","author":"Pokorski","year":"1988","unstructured":"Pokorski RJ. Mortality Methodology and Analysis Seminar Text. Sponsored by the Association of Life Insurance Medical Directors of America. J Insur Med 1988;20:1\u201326."},{"key":"i-52-3-148-ref12","series-title":"Annals of Oncology","first-page":"1719","article-title":"Definition of disease-free survival: This is my truth \u2013 show me yours","volume":"16","author":"Chua","year":"2005","unstructured":"Chua YJ,\nSargent D,\nCunningham D. Editorial. Definition of disease-free survival: This is my truth \u2013 show me yours. Annals of Oncology 2005;16:1719\u20131721."},{"key":"i-52-3-148-ref13","series-title":"Medical Risks: Patterns of Mortality and Survival","author":"Singer","year":"1976","unstructured":"Singer RB,\nLevinson L (eds). Medical Risks: Patterns of Mortality and Survival. Lexington, MA: Lexington Books, 1976; chapters 2 and 3."},{"key":"i-52-3-148-ref14","series-title":"Medical Risks: Trends in Mortality by Age and Time Elapsed","author":"Lew","year":"1990","unstructured":"Lew EA,\nGajewski J (eds). Medical Risks: Trends in Mortality by Age and Time Elapsed. New York: Praeger, 1990; chapter 1."},{"key":"i-52-3-148-ref15","series-title":"Medical Selection of Life Risks","author":"Brackenridge","year":"2006","unstructured":"Brackenridge RDC,\nCroxson RS,\nMackenzie R, eds. Medical Selection of Life Risks, 5th ed. New York; Palgrave Macmillan, 2006; chapters 3\u20135."},{"key":"i-52-3-148-ref16","first-page":"1","article-title":"Estimating relative survival for cancer patients from the SEER Program using expected rates based on Ederer I versus Ederer II method. Surveillance Research Program","author":"Cho","year":"2011","unstructured":"Cho H,\nHowlader N,\nMariotto AB,\nCronin KA. Estimating relative survival for cancer patients from the SEER Program using expected rates based on Ederer I versus Ederer II method. Surveillance Research Program, National Cancer Institute; 2011. Technical Report #2011-01:1\u201317. Available from: https:\/\/surveillance.cancer.gov\/reports\/"},{"article-title":"SEER*Explorer: An interactive website for SEER cancer statistics [Internet]","year":"2025","key":"i-52-3-148-ref17","unstructured":"SEER*Explorer: An interactive website for SEER cancer statistics [Internet]. Surveillance Research Program, National Cancer Institute; 2025 Apr 16. [cited 2025 Jun 22]. Available from: https:\/\/seer.cancer.gov\/statistics-network\/explorer\/. Data source(s): SEER Incidence Data, November 2024 Submission (1975-2022), SEER 21 registries."},{"article-title":"SEER*Explorer: An interactive website for SEER cancer statistics [Internet]","year":"2025","key":"i-52-3-148-ref18","unstructured":"SEER*Explorer: An interactive website for SEER cancer statistics [Internet]. Surveillance Research Program, National Cancer Institute; 2025 Apr 16. [cited 2025 Jun 22]. Available from: https:\/\/seer.cancer.gov\/statistics-network\/explorer\/. Data source(s): U.S. 2022 cancer prevalence estimates are based on 2022 cancer prevalence proportions from the SEER 12 Areas (excluding the Alaska Native Tumor Registry) and 1\/1\/2022 U.S. population estimates based on the average of 2021 and 2022 population estimates from the U.S. Bureau of the Census."},{"key":"i-52-3-148-ref19","series-title":"Cancers","first-page":"2256","article-title":"Etiology of Acute Leukemia: A Review","volume":"13","author":"Tebbi,","year":"2021","unstructured":"Tebbi, CK. Etiology of Acute Leukemia: A Review. Cancers. 2021;13:2256. https:\/\/doi.org\/10.3390\/cancers13092256. https:\/\/www.mdpi.com\/journal\/cancers"},{"key":"i-52-3-148-ref020","series-title":"Cold Spring Harb Perspect Med","first-page":"a034819","article-title":"Epidemiology and Etiology of Leukemia and Lymphoma","volume":"10","author":"Bispo","year":"2020","unstructured":"Bispo J,\nPinheiro P,\nKobetz E. Epidemiology and Etiology of Leukemia and Lymphoma. Cold Spring Harb Perspect Med. 2020;10:a034819. Accessed at www.perspectivesinmedicine.org"},{"key":"i-52-3-148-ref021","series-title":"Cancer","first-page":"981","article-title":"Top Advances of the Year in Leukemia: 2021","volume":"129","author":"Kent","year":"2023","unstructured":"Kent A,\nPollyea DA. Top Advances of the Year in Leukemia: 2021. Cancer. 2023;129:981\u2013985. doi:10.1002\/cncr.34619"},{"article-title":"The Leukemia & Lymphoma Society. Facts 2023-2024","year":"2024","key":"i-52-3-148-ref022","unstructured":"The Leukemia & Lymphoma Society. Facts 2023-2024. Updated Data on Blood Cancers. Published August 2024. Accessed at https:\/\/lls.org\/booklet\/facts-updated-data-blood-cancers"}],"container-title":["Journal of Insurance Medicine"],"original-title":[],"link":[{"URL":"https:\/\/jim.kglmeridian.com\/view\/journals\/insm\/52\/3\/article-p148.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jim.kglmeridian.com\/downloadpdf\/journals\/insm\/52\/3\/article-p148.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jim.kglmeridian.com\/downloadpdf\/journals\/insm\/52\/3\/article-p148.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:57:00Z","timestamp":1760144220000},"score":1,"resource":{"primary":{"URL":"https:\/\/jim.kglmeridian.com\/view\/journals\/insm\/52\/3\/article-p148.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":22,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.17849\/insm-52-3-1-32.1","relation":{},"ISSN":["0743-6661"],"issn-type":[{"type":"print","value":"0743-6661"}],"subject":[],"published":{"date-parts":[[2025]]}}}